(VIANEWS) – The NASDAQ ended the session with TherapeuticsMD (TXMD) jumping 11.55% to $5.89 on Friday while NASDAQ rose 1.79% to $11,452.42.


Today’s last reported volume for TherapeuticsMD is 530791, 61.51% below its average volume of 1379240.

TherapeuticsMD’s last close was $5.28, 92% higher than its 52-week high of $2.75.

TherapeuticsMD’s Sales

TherapeuticsMD’s sales growth is 33.7% for the current quarter and 29.3% for the next. The company’s growth estimates for the ongoing quarter and the next is 16.7% and 40%, respectively.

TherapeuticsMD’s Revenue

Year-on-year quarterly revenue growth grew by 114.9%, now sitting on 84.79M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

TherapeuticsMD’s stock is considered to be overbought (>=80).

TherapeuticsMD’s Stock Yearly Top and Bottom Value

TherapeuticsMD’s stock is valued at $5.89 at 20:18 EST, way higher than its 52-week high of $2.75.

TherapeuticsMD’s Moving Average

TherapeuticsMD’s worth is way above its 50-day moving average of $0.66 and way higher than its 200-day moving average of $1.00.

More news about TherapeuticsMD (TXMD).


Please enter your comment!
Please enter your name here